About
Siga Tech
SIGA.US
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company’s lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.
Profile
- Company Name
- SIGA Technologies, Inc.
- Market
- NasdaqGM
- Founded
- Industry
- --
- Fiscal Year End
- December 31
- Website
- www.siga.com